4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000151
Executive Chair sold 26,756 shares at an average $90.01 ($2,408,242)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SAYER KEVIN R · Executive Chair
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-20 | Sale : show line 1 in the form 10b5-1 | −19,308 | $89.71 | $1,732,043 | 309,662 | D |
| 2026-08-20 | Sale : show line 2 in the form 10b5-1 | −7,351 | $90.78 | $667,332 | 302,311 | D |
| 2026-08-20 | Sale : show line 3 in the form 10b5-1 | −97 | $91.41 | $8,867 | 302,214 | D |
| Open-market sales · 26,756 sh · avg $90.01 · $2,408,242 | ||||||
Loading xslF345X06/wk-form4_1787601701.xml…